Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer

RNA

Volumn 13, Issue 12, 2007, Pages 2287-2299

  Dallosso, Anthony R ^a   Hancock, Anne L ^a   Malik, Sally ^a   Salpekar, Ashreena ^a   King Underwood, Linda ^b   Pritchard Jones, Kathy ^b   Peters, Jo ^c   Moorwood, Kim ^d   Ward, Andrew ^d   Malik, Karim T A ^a   Brown, Keith W ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c MRC MAMMALIAN GENETICS UNIT   (United Kingdom)

^d University of Bath   (United Kingdom)

Author keywords

Antisense; Epigenetics; Heteroduplex; RNA; Splicing; WT1

Indexed keywords

COMPLEMENTARY RNA; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIGENETICS; EXON; HUMAN; HUMAN TISSUE; INTRON; MOUSE; NEPHROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN RNA BINDING; RNA DEGRADATION; RNA SPLICING;

ALTERNATIVE SPLICING; ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; LEUKEMIA, MYELOID, ACUTE; MICE; MUTATION; NEOPLASM PROTEINS; RNA, ANTISENSE; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; WILMS TUMOR; WT1 PROTEINS;

MAMMALIA;

EID: 36249026230     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.562907     Document Type: Article

References (61)

1. Brannan, C.I., Dees, E.C., Ingram, R.S., and Tilghman, S.M. 1990. The product of the H19 gene may function as an RNA. Mol. Cell. Biol. 10: 28-36.
2. Brightwell, G., Poirier, V., Cole, E., Ivins, S., and Brown, K.W. 1997. Serum-dependent and cell cycle-dependent expression from a cytomegalovirus-based mammalian expression vector. Gene 194: 115-123.
3. Brown, K.W., Watson, J.E., Poirier, V., Mott, M.G., Berry, P.J., and Maitland, N.J. 1992. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient. Oncogene 7: 763-768.
4. Brown, K.W., Wilmore, H.P., Watson, J.E., Mott, M.G., Berry, P.J., and Maitland, N.J. 1993. Low frequency of mutations in the WT1 coding region in Wilms' tumor. Genes Chromosomes Cancer 8: 74-79.
5. Caballero, O.L., Souza, S.J., Brentani, R.R., and Simpson, A.J. 2001. Alternative spliced transcripts as cancer markers. Dis. Markers 17: 67-75.
6. Caceres, J.F. and Kornblihtt, A.R. 2002. Alternative splicing: Multiple control mechanisms and involvement in human disease. Trends Genet. 18: 186-193.
7. Campbell, C.E., Huang, A., Gurney, A.L., Kessler, P.M., Hewitt, J.A., and Williams, B.R.G. 1994. Antisense transcripts and protein binding motifs within the Wilms tumour (WT1) locus. Oncogene 9: 583-595.
8. Chen, J., Sun, M., Kent, W.J., Huang, X., Xie, H., Wang, W., Zhou, G., Shi, R.Z., and Rowley, J.D. 2004. Over 20% of human transcripts might form sense-antisense pairs. Nucleic Acids Res. 32: 4812-4820. doi: 10.1093/nar/gkh818.
9. Chen, J., Sun, M., Hurst, L.D., Carmichael, G.G., and Rowley, J.D. 2005. Genome-wide analysis of coordinate expression and evolution of human cis-encoded sense-antisense transcripts. Trends Genet. 21: 326-329.
10. Chen, J.L., Blasco, M.A., and Greider, C.W. 2000. Secondary structure of vertebrate telomerase RNA. Cell 100: 503-514.
11. Cocquet, J., Pannetier, M., Fellous, M., and Veitia, R.A. 2005. Sense and antisense Foxl2 transcripts in mouse. Genomics 85: 531-541.
12. Costello, J.F., Fruhwald, M.C., Smiraglia, D.J., Rush, L.J., Robertson, G.P., Gao, X., Wright, F.A., Feramisco, J.D., Peltomaki, P., Lang, J.C., et al. 2000. Aberrant CpG-island methylation has nonrandom and tumour-type-specific patterns. Nat. Genet. 24: 132-138.
13. Dallosso, A.R., Hancock, A.L., Brown, K.W., Williams, A.C., Jackson, S., and Malik, K. 2004. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours. Hum. Mol. Genet. 13: 405-415.
14. Eccles, M.R., Grubb, G., Ogawa, O., Szeto, J., and Reeve, A.E. 1994. Cloning of novel Wilms' tumor gene (WT1) cDNAs: Evidence for antisense transcription of WT1. Oncogene 9: 2059-2063.
15. Fraizer, G.C., Wu, Y.J., Hewitt, S.M., Maity, T., Ton, C.C.T., Huff, V., and Saunders, G.F. 1994. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter. J. Biol. Chem. 269: 8892-8900.
16. Gessler, M. and Bruns, G.A.P. 1993. Sequence of the WT1 upstream region including the Wit-1 gene. Genomics 17: 499-501.
17. Gong, Y., Eggert, H., and Englert, C. 2001. The murine Wilms' tumor suppressor gene (wt1) locus. Gene 279: 119-126.
18. Hancock, A.L., Brown, K.W., Moorwood, K., Moon, H., Holmgren, C., Mardikar, S.H., Dallosso, A.R., Klenova, E., Loukinov, D., Ohlsson, R., et al. 2007. A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS, and exhibits sequential epigenetic defects during Wilms' tumourigenesis. Hum. Mol. Genet. 16: 344-354.
19. Hofmann, W., Royer, H.D., Drechsler, M., Schneider, S., and Royerpokora, B. 1993. Characterization of the transcriptional regulatory region of the human WT1 gene. Oncogene 8: 3123-3132.
20. Hohenstein, P. and Hastie, N.D. 2006. The many facets of the Wilms' tumour gene, WT1. Hum. Mol. Genet. 15: R196-R201. doi: 10.1093/hmg/ddi196.
21. Huang, A., Campbell, C.E., Bonetta, L., McAndrews Hill, M.S., Chiltonm MacNeill, S., Coppes, M.J., Law, D.J., Feinberg, A.P., Yeger, H., and Williams, B.R. 1990. Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms' tumor. Science 250: 991-994.
22. Huang, T.H.-M., Laux, D.E., Hamlin, B.C., Tran, P., Tran, H., and Lubahn, D.B. 1997. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res. 57: 1030-1034.
23. Hutchinson, J.N., Ensminger, A.W., Clemson, C.M., Lynch, C.R., Lawrence, J.B., and Chess, A. 2007. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics 8: 39.
24. Imamura, T., Yamamoto, S., Ohgane, J., Hattori, N., Tanaka, S., and Shiota, K. 2004. Non-coding RNA directed DNA demethylation of Sphk1 CpG island. Biochem. Biophys. Res. Commun. 322: 593-600.
25. Juan, V., Crain, C., and Wilson, C. 2000. Evidence for evolutionarily conserved secondary structure in the H19 tumor suppressor RNA. Nucleic Acids Res. 28: 1221-1227.
26. Kaneuchi, M., Sasaki, M., Tanaka, Y., Shiina, H., Yamada, H., Yamamoto, R., Sakuragi, N., Enokida, H., Verma, M., and Dahiya, R. 2005. WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Cancer 104: 1924-1930.
27. Katayama, S., Tomaru, Y., Kasukawa, T., Waki, K., Nakanishi, M., Nakamura, M., Nishida, H., Yap, C.C., Suzuki, M., Kawai, J., et al. 2005. Antisense transcription in the mammalian transcriptome. Science 309: 1564-1566.
28. Keirsebilck, A., Bonne, S., Staes, K., van Hengel, J., Nollet, F., Reynolds, A., and van Roy, F. 1998. Molecular cloning of the human p120ctn catenin gene (CTNND1): Expression of multiple alternatively spliced isoforms. Genomics 50: 129-146.
29. Kelley, R.L. and Kuroda, M.I. 2000. Noncoding RNA genes in dosage compensation and imprinting. Cell 103: 9-12.
30. Kent, J., Lee, M., Schedl, A., Boyle, S., Fantes, J., Powell, M., Rushmere, N., Abbott, C., Van, H.V., and Bickmore, W.A. 1997. The reticulocalbin gene maps to the WAGR region in human and to the Small eye Harwell deletion in mouse. Genomics 42: 260-267.
31. Kimura, M.I., Kazuki, Y., Kashiwagi, A., Kai, Y., Abe, S., Barbieri, O., Levi, G., and Oshimura, M. 2004. Dlx5, the mouse homologue of the human-imprinted DLX5 gene, is biallelically expressed in the mouse brain. J. Hum. Genet. 49: 273-277.
32. King-Underwood, L., Renshaw, J., and Pritchardjones, K. 1996. Mutations in the Wilms' tumor gene WT1 in leukemias. Blood 87: 2171-2179.
33. King-Underwood, L. and Pritchard-Jones, K. 1998. Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. Blood 91: 2961-2968.
34. Kleymenova, E.V., Yuan, X., LaBate, M.E., and Walker, C.L. 1998. Identification of a tumor-specific methylation site in the Wilms' tumor suppressor gene. Oncogene 16: 713-720.
35. Krystal, G.W., Armstrong, B.C., and Battey, J.F. 1990. N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts. Mol. Cell. Biol. 10: 4180-4191.
36. Lanz, R.B., McKenna, N.J., Onate, S.A., Albrecht, U., Wong, J., Tsai, S.Y., Tsai, M.J., and O'Malley, B.W. 1999. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97: 17-27.
37. Lehner, B., Williams, G., Campbell, R.D., and Sanderson, C.M. 2002. Antisense transcripts in the human genome. Trends Genet. 18: 63-65.
38. Little, M. and Wells, C. 1997. A clinical overview of WT1 gene mutations. Hum. Mutat. 9: 209-225.
39. Little, M.H., Dunn, R., Byrne, J.A., Seawright, A., Smith, P.J., Pritchard-Jones, K., Vanheyningen, V., and Hastie, N.D. 1992. Equivalent expression of paternally and maternally inherited WT1 alleles in normal fetal tissue and Wilms' tumours. Oncogene 7: 635-641.
40. Luedi, P.P., Hartemink, A.J., and Jirtle, R.L. 2005. Genome-wide prediction of imprinted murine genes. Genome Res. 15: 875-884.
41. Malik, K., Salpekar, A., Hancock, A., Moorwood, K., Jackson, S., Charles, A., and Brown, K.W. 2000. Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms' tumor. Cancer Res. 60: 2356-2360.
42. Malik, K.T., Wallace, J.I., Ivins, S.M., and Brown, K.W. 1995. Identification of an antisense WT1 promoter in intron 1: Implications for WT1 gene regulation. Oncogene 11: 1589-1595.
43. Moorwood, K., Charles, A.K., Salpekar, A., Wallace, J.I., Brown, K.W., and Malik, K. 1998. Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro. J. Pathol. 185: 352-359.
44. Morison, I.M., Ramsay, J.P., and Spencer, H.G. 2005. A census of mammalian imprinting. Trends Genet. 21: 457-465.
45. O'Neill, M.J. 2005. The influence of noncoding RNAs on allele-specific gene expression in mammals. Hum. Mol. Genet. (Suppl. 1) 14: R113-R120. doi: 10.1093/hmg/ddi108.
46. Pelletier, J., Schalling, M., Buckler, A.J., Rogers, A., Haber, D.A., and Housman, D. 1991. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes & Dev. 5: 1345-1356.
47. Plass, C., Yu, F., Yu, L., Strout, M.P., El Rifai, W., Elonen, E., Knuutila, S., Marcucci, G., Young, D.C., Held, W.A., et al. 1999. Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene. Oncogene 18: 3159-3165.
48. Podlowski, S., Bramlage, P., Baumann, G., Morano, I., and Luther, H.P. 2002. Cardiac troponin I sense-antisense RNA duplexes in the myocardium. J. Cell. Biochem. 85: 198-207.
49. Pritchard Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., and Housman, D. 1990. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346: 194-197.
50. Roberts, S.G. 2005. Transcriptional regulation by WT1 in development. Curr. Opin. Genet. Dev. 15: 542-547.
51. Roy, M., Xu, Q., and Lee, C. 2005. Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms. Nucleic Acids Res. 33: 5026-5033. doi: 10.1093/nar/gki792.
52. Scharnhorst, V., Van der Eb, A.J., and Jochemsen, A.G. 2001. WT1 proteins: Functions in growth and differentiation. Gene 273: 141-161.
53. Seidl, C.I., Stricker, S.H., and Barlow, D.P. 2006. The imprinted Air ncRNA is an atypical RNAPII transcript that evades splicing and escapes nuclear export. EMBO J. 25: 3565-3575.
54. Sleutels, F., Zwart, R., and Barlow, D.P. 2002. The noncoding Air RNA is required for silencing autosomal imprinted genes. Nature 415: 810-813.
55. Thakur, N., Tiwari, V.K., Thomassin, H., Pandey, R.R., Kanduri, M., Gondor, A., Grange, T., Ohlsson, R., and Kanduri, C. 2004. An antisense RNA regulates the bidirectional silencing property of the Kcnq1 imprinting control region. Mol. Cell. Biol. 24: 7855-7862.
56. Timmons, J.A. and Good, L. 2006. Does everything now make (anti)sense? Biochem. Soc. Trans. 34: 1148-1150.
57. Vu, T.H., Chuyen, N.V., Li, T., and Hoffman, A.R. 2003. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. Cancer Res. 63: 1900-1905.
58. Williamson, C.M., Skinner, J.A., Kelsey, G., and Peters, J. 2002. Alternative non-coding splice variants of Nespas, an imprinted gene antisense to Nesp in the Gnas imprinting cluster. Mamm. Genome 13: 74-79.
59. Ye, Y., Raychaudhuri, B., Gurney, A., Campbell, C.E., and Williams, B.R.G. 1996. Regulation of WT1 by phosphorylation: Inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO J. 15: 5606-5615.
60. Yeger, H., Cullinane, C., Flenniken, A., Chilton-MacNeil, S., Campbell, C., Huang, A., Bonetta, L., Coppes, M.J., Thorner, P., and Williams, B.R. 1992. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes. Cell Growth Differ. 3: 855-864.
61. Yelin, R., Dahary, D., Sorek, R., Levanon, E.Y., Goldstein, O., Shoshan, A., Diber, A., Biton, S., Tamir, Y., Khosravi, R., et al. 2003. Widespread occurrence of antisense transcription in the human genome. Nat. Biotechnol. 21: 379-386.